Archives of Pharmacal Research

, 28:1376

Hepatoprotective constituents of the edible brown algaEcklonia stolonifera on tacrine-induced cytotoxicity in hep G2 cells

  • Youn Chul Kim
  • Ren Bo An
  • Na Young Yoon
  • Taek Jeong Nam
  • Jae Sue Choi
Articles Drug Development

Abstract

In this study, ethanolic extracts from 18 seaweed variants were assessed for hepatoprotective activity against tacrine-induced cytotoxicity in Hep G2 cells. Only one of these,Ecklonia stolonifera Okamura (Laminariaceae), a member of the brown algae, exhibited promising hepatoprotective activity. Bioassay-guided fractionation of the active ethyl acetate (EtOAc) soluble fraction obtained from the ethanolic extract ofE. stolonifera, resulted in the isolation of several phlorotannins [phloroglucinol (1), eckstolonol (2), eckol (3), phlorofucofuroeckol A (4), and dieckol (5)]. Compounds 2 and 4 were determined to protect Hep G2 cells against the cytotoxic effects of tacrine, with EC50 values of 62.0 and 79.2 μg/mL, respectively. Silybin, a well characterized hepatoprotective agent, was used as a positive control, and exhibited an EC50 value of 50.0 μg/mL. It has been suggested that the phlorotannins derived from marine brown algae might prove useful sources in the development of novel hepatoprotective agents.

Key words

Ecklonia stolonifera Hepatoprotective Phlorotannins Marine algae Tacrine Hep G2 cells 

References

  1. An, R. B., Kim, H. C., Tian, Y. H., and Kim, Y. C., Free radical scavenging and hepatoprotective constituents from the leaves ofJuglans sinensis.Arch. Pharm. Res., 28, 529–533 (2005).PubMedGoogle Scholar
  2. Choi, J. S., Lee, J. H., Park, H. J., Kim, H. G., Young, H. S., and Mun, S. I., Screening for antioxidant activity of plant and marine algae and its active principles fromPrunus davidiana.Kor. J. Pharmacogn., 24, 299–303 (1993).Google Scholar
  3. Fukuyama, Y., Miura, I., Kinzyo, Z., Mori, H., Kido, M., Nakayama, Y., Takahashi, M., and Ochi, M., Eckols, novel phlorotannins with a dibenzo-p-dioxin skeleton possessing inhibitory effects on α2-macroglobulin from the brown algaEcklonia kurome Okamura.Chem. Lett., 739–742 (1985).Google Scholar
  4. Fukuyama, Y., Kodarna, M., Miura, I., Kinzyo, Z., Kido, M., Mori, H., Nakayama, Y., and Takahashi, M., Structure of an anti-plasmin inhibitor, eckol, isolated from the brown algaEcklonia kurome Okamura and inhibitory activities of its derivatives on plasma plasmin inhibitors.Chem. Pharm. Bull., 37, 349–353 (1989a).PubMedGoogle Scholar
  5. Fukuyama, Y., Kodarna, M., Miura, I., Kinzyo, Z., Mori, H., Nakayama, Y., and Takahashi, M., Anti-plasmin inhibitor. V. Structures of novel dimeric eckols isolated from the brown algaEcklonia kurome Okamura.Chem. Pharm. Bull., 37, 2438–2440 (1989b).PubMedGoogle Scholar
  6. Fukuyama, Y., Kodarna, M., Miura, I., Kinzyo, Z., Mori, H., Nakayama, Y., and Takahashi, M., Anti-plasmin inhibitor. VI. Structure of phlorofucofuroeckol A, a novel phlorotannin with both dibenzo-1,4-dioxin and dibenzofuran elements, from the brown algaEcklonia kurome Okamura.Chem. Pharm. Bull., 38,133–135 (1990).PubMedGoogle Scholar
  7. Grant, M. H., Duthie, S. J., Gray, A. G., and Burke, M. D., Mixed function oxidase and UDP-glucuronyltransferase activities in the human Hep G2 hepatoma cell line.Biochem. Pharmacol., 37, 4111–4116 (1988).PubMedCrossRefGoogle Scholar
  8. Han, E. S., Kim, J. W., Eom, M. O., Kang, I. H., Kang, H. J., Choi, J. S., Ha, K. W., and Oh, H. Y, Inhibitory effects ofEcklonia stolonifera on gene mutation on mouse lymphoma tk+/- locus in L5178Y-3.7.2C cell and bone marrow micronuclei formation in ddY mice.Environ. Mutagen. Carcinogen., 20, 104–111 (2000).Google Scholar
  9. Higa, T., Phenolic substances. In Scheuer, P. J. (Ed.). Marine Natural Products, Chemical and Biological Perspectives. Vol. IV. Academic Press, New York, pp. 119–123 (1981).Google Scholar
  10. Jung, H. A., Chung, H. Y, Yokozawa, T., Kim, Y. C., Hyun, S. and Choi, J. S., Alaternin and emodin with hydroxyl radical inhibitory and/or scavenging activities and hepatoprotective activity on tacrine-induced cytotoxicity in Hep G2 cells.Arch. Pharm. Res., 27, 947–953 (2004).PubMedCrossRefGoogle Scholar
  11. Kang, H. S., Chung, H. Y, Jung, J. H., Son, B. W., and Choi, J. S., A new phlorotannin from the brown algaEcklonia stolonifera.Chem. Pharm. Bull., 51, 1012–1014 (2003).PubMedCrossRefGoogle Scholar
  12. Kang, H. S., Kim, H. R., Byun, D. S., Son, B. W., Nam, T. J., and Choi, J. S., Tyrosinase inhibitors isolated from the edible brown algaEcklonia stolonifera.Arch. Pharm. Res., 27,1226–1232 (2004).PubMedCrossRefGoogle Scholar
  13. Kurata, K., Taniguchi, K., Shiraishi, K., Hayama, N., Tanaka, I., and Suzuki, M., Ecklonialactone-A and -B, two unusual metabolites from the brown algae Ecklonia stolonifera Okamura.Chem. Lett., 267–270 (1989).Google Scholar
  14. Kurata, K., Taniguchi, K., Shiraishi, K., and Suzuki, M., Ecklonialactones C-F from the brown algaEcklonia stolonifera.Phytochemistry, 33, 155–159 (1993).CrossRefGoogle Scholar
  15. Lee, J. H., Park, J. C., and Choi, J. S., The antioxidant activity ofEcklonia stolonifera.Arch. Pharm. Res., 19, 223–227 (1996).CrossRefGoogle Scholar
  16. Lee, J. H., Kim, N. D., Choi, J. S., Kim, Y. J., Moon, Y. H.., Lim, S. Y., and Park, Y., Inhibitory effects of the methanolic extract of an edible brown alga,Ecklonia stolonifera and its component, phloroglucinol on aflatoxin B1 mutagenicityin vitro (Ames test) and on benzo(a)pyrene or N-methyl N-nitrosourea clastogenicityin vivo (mouse micronucleus test).Nat. Prod. Sci., 4, 105–114 (1998).Google Scholar
  17. Nakamura, T., Nagayama, K., Uchida, K., and Tanaka, R., Antioxidant activity of phlorotannins isolated from the brown algaEisenia bicyclis.Fish Sci., 62, 923–926 (1996).Google Scholar
  18. Osseni, R. A., Debbasch, C., Christen, M. O., Rat, P., and Warnet, J. M., Tacrine-induced reactive oxygen species in a human liver cell line: the role of anethole dithiolethione as a scavenger.Toxicol. In Vitro, 13, 683–688 (1999).CrossRefGoogle Scholar
  19. Park, E. J., Oh, H., Kang, T. H., Sohn, D. H., and Kim, Y. C., An isocoumarin with hepatoprotective activity in Hep G2 and primary hepatocytes fromAgrimonia pilosa.Arch. Pharm. Res., 27, 944–946 (2004).PubMedCrossRefGoogle Scholar
  20. Song, E. K., Cho, H., Kim, J. S., Kim, N. Y, An, N. H., Kim, J. A., Lee, S. H., and Kim, Y. C., Diarylheptanoids with free radical scavenging and hepatoprotective activityin vitro fromCurcuma longa.Planta Med., 67, 876–877 (2001).PubMedCrossRefGoogle Scholar
  21. Taniguchi, K., Kurata, K., and Suzuki, M., Feeding-deterrent effect of phlorotannins from the brown algaEcklonia stolonifera against the abaloneHaliotis discus Hannai.Nippon Suisan Gakkaishi, 57, 2065–2071 (1991).Google Scholar
  22. Viau, J., Curren, R. D., and Wallace, K.., Cytotoxicity of tacrine and velnacrine metabolites in cultured rat, dog, and human hepatocytes.Drug Chem. Toxicol., 16, 227–239 (1993).PubMedCrossRefGoogle Scholar
  23. Watkins, P. B., Zimmerman, H. J., Knapp, M. J., Gracon, S. I., and Lewis, K. W., Hepatotoxic effects of tacrine administration in patients with Alzheimer’s disease.J. Am. Med. Assoc, 271, 992–998 (1994).CrossRefGoogle Scholar

Copyright information

© The Pharmaceutical Society of Korea 2005

Authors and Affiliations

  • Youn Chul Kim
    • 3
  • Ren Bo An
    • 1
  • Na Young Yoon
    • 2
  • Taek Jeong Nam
    • 2
  • Jae Sue Choi
    • 2
  1. 1.College of PharmacyYanbian UniversityYanji, JilinChina
  2. 2.Faculty of Food Science and BiotechnologyPukyong National UniversityBusanKorea
  3. 3.College of PharmacyWonkwang UniversityIksanKorea

Personalised recommendations